These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1342 related articles for article (PubMed ID: 18852635)
1. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease. Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635 [TBL] [Abstract][Full Text] [Related]
2. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease. Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364 [TBL] [Abstract][Full Text] [Related]
4. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease. Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007 [TBL] [Abstract][Full Text] [Related]
5. Altered small-bowel mucosal vascular network in untreated coeliac disease. Myrsky E; Syrjänen M; Korponay-Szabo IR; Mäki M; Kaukinen K; Lindfors K Scand J Gastroenterol; 2009; 44(2):162-7. PubMed ID: 18985542 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet. Bazzigaluppi E; Roggero P; Parma B; Brambillasca MF; Meroni F; Mora S; Bosi E; Barera G Dig Liver Dis; 2006 Feb; 38(2):98-102. PubMed ID: 16386476 [TBL] [Abstract][Full Text] [Related]
9. Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease. Koskinen O; Lindfors K; Collin P; Peräaho M; Laurila K; Woolley N; Partanen J; Mäki M; Kaukinen K Dig Liver Dis; 2010 Oct; 42(10):692-7. PubMed ID: 20409763 [TBL] [Abstract][Full Text] [Related]
10. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Salmi TT; Collin P; Järvinen O; Haimila K; Partanen J; Laurila K; Korponay-Szabo IR; Huhtala H; Reunala T; Mäki M; Kaukinen K Aliment Pharmacol Ther; 2006 Aug; 24(3):541-52. PubMed ID: 16886921 [TBL] [Abstract][Full Text] [Related]
12. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis. Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382 [TBL] [Abstract][Full Text] [Related]
13. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study. Carroccio A; Brusca I; Iacono G; Alessio MG; Sonzogni A; Di Prima L; Barrale M; Ottomano C; Ambrosiano G; Teresi S; D'Angelo A; Pirrone G; Cefalù B; Scalici C; La Chiusa SM Dig Liver Dis; 2007 Sep; 39(9):818-23. PubMed ID: 17652043 [TBL] [Abstract][Full Text] [Related]
14. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease? Lindfors K; Kaukinen K; Mäki M Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945 [TBL] [Abstract][Full Text] [Related]
16. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. Akbari MR; Mohammadkhani A; Fakheri H; Javad Zahedi M; Shahbazkhani B; Nouraie M; Sotoudeh M; Shakeri R; Malekzadeh R Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1181-6. PubMed ID: 17033439 [TBL] [Abstract][Full Text] [Related]
17. Tissue transglutaminase in celiac disease: role of autoantibodies. Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381 [TBL] [Abstract][Full Text] [Related]
18. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568 [TBL] [Abstract][Full Text] [Related]
19. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Kaukinen K; Sulkanen S; Mäki M; Collin P Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):311-5. PubMed ID: 11953698 [TBL] [Abstract][Full Text] [Related]